HARTE HANKS INC (HHS) research
HARTE HANKS INC- Sector
- Industrials
- Industry
- Conglomerates
- Last price
- $4.56
- As of
HARTE HANKS INC (HHS): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-15.
As of . Source: SEC EDGAR filings for HHS. Method and limitations.
Share the HHS intelligence card
See the full HHS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for HHS on one page. Preview it with sample data, then open it live with a free account.
Preview the HHS dossierActive signals for HHS
- mediumEARNINGS_MISS
Q3-2024: Missed consensus by 80.2% - EPS $0.02 vs $0.101 estimate
- lowEARNINGS_BEAT
Q1-2024: EPS $-0.02 vs $-0.0404 estimate, +0.02 on a near-zero consensus
- mediumEARNINGS_BEAT
Q2-2024: Beat consensus by 2692.1% - EPS $1.41 vs $0.0505 estimate
- mediumEARNINGS_MISS
Missed consensus by 80.2% - EPS $0.02 vs $0.101 estimate
FREE, NO ACCOUNT
Every signal on HHS, as it fires
New filings, 13F moves and cross asset signals on HHS land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in HHS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 416196202 · 2026Q2 | $46K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, HHS
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
HHS mentioned in Kresmion daily briefs
HHS against its peers
HHS's operating margin of 0.2% ranks in the 68th percentile of 16 Conglomerates sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-03-31.
| Metric | HHS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 160M USD | 172M USD | 47 | 17 |
| Gross margin | n/a | 24.7% | n/a | 11 |
| Operating margin | 0.2% | -3.4% | 68 | 16 |
| Net margin | -0.5% | 0.2% | 43 | 19 |
| Return on equity | -4.0% | 0.5% | 34 | 18 |
| P / E | n/a | 23.8x | n/a | 6 |
Peers (19): STRR, GPUS, LGPS, AIRT, ATVK, PLAG, BOOM, TUSK, MAMK, RCMT, NNBR, FIP, BOC, FBYD, TRC, CRESY, TTI, DLX, BBUC. Left out: BBXIB (period gap), SITS (period gap), AIAI (no annual filing), KRTL (no annual filing), MATW (no annual filing), PAM (period gap). Fiscal periods ending between 2025-06-30 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (HHS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more HHS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HHSand get the insider, 13F, options, and confluence read in one view.